Table 1

Clinicopathological features of the cohort of 470 grade III invasive ductal carcinomas of no special type

Parameter

Number


Age in years

Range

21–85 (mean 53.2)

<35

36 (8%)

35–50

142 (32%)

51–65

189 (43%)

>65

76 (17%)

Menopausal status

Premenopausal

175 (40%)

Perimenopausal

64 (15%)

Postmenopausal

195 (45%)

Unknown

9

Tumour size

Range

0.5–10.5 cm (mean 3.4 cm)

p1

27 (6%)

p2

313 (72%)

p3

93 (21%)

Axillary nodes

Positive

251 (57%)

Negative

184 (42%)

Oestrogen receptor

Positive

191 (46%)

Negative

222 (54%)

Not available

30

Surgical management

None

2 (1%)

Mastectomy

318 (72%)

Tumourectomy

123 (28%)

Adjuvant treatment

None

229 (52%)

Tamoxifen/Ovarian oblation

103 (22%)

Chemotherapy and tamoxifen

5 (1%)

Chemotherapy

112 (25%)

Length of follow-up in months

3.2–333.5 (mean 116.4)


Tumour sizes: p1, <2 cm; p2, 2–5 cm; p3, >5 cm.

Fulford et al. Breast Cancer Research 2007 9:R4   doi:10.1186/bcr1636

Open Data